These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 6621123)

  • 1. [Tumor markers].
    Ruibal Morell A
    Med Clin (Barc); 1983 May; 80(17):752-4. PubMed ID: 6621123
    [No Abstract]   [Full Text] [Related]  

  • 2. Tumor antigens as surrogate markers and targets for therapy and vaccines.
    Dalgleish A; Pandha H
    Adv Cancer Res; 2007; 96():175-90. PubMed ID: 17161680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Enzyme immunoassay in the detection of tumor markers].
    Pácsa S
    Morphol Igazsagugyi Orv Sz; 1983 Apr; 23(2):119-26. PubMed ID: 6346071
    [No Abstract]   [Full Text] [Related]  

  • 4. [Tumor-associated antigens and their importance in tumor diagnosis].
    von Kleist S
    Verh Dtsch Ges Inn Med; 1980; 86():503-6. PubMed ID: 7223038
    [No Abstract]   [Full Text] [Related]  

  • 5. International conference on human tumor markers. Biological basis and clinical relevance. Munich, Germany FR June 17-20, 1982. Abstracts.
    Cancer Detect Prev; 1982; 5(2):231-81. PubMed ID: 7127344
    [No Abstract]   [Full Text] [Related]  

  • 6. Tumor immunology.
    Stevenson H; Tsang KY
    Immunol Ser; 1993; 58():497-515. PubMed ID: 8424991
    [No Abstract]   [Full Text] [Related]  

  • 7. Tumor-associated antigens and the role of antibodies and cellular immunity in cancer. Introduction.
    Vose B
    Immunol Ser; 1994; 61():1-2. PubMed ID: 8011734
    [No Abstract]   [Full Text] [Related]  

  • 8. Cellular and humoral immune responses of cancer patients to defined tumor antigens.
    Jäger D; Jäger E; Bert F; Knuth A
    Cancer Chemother Biol Response Modif; 2001; 19():385-93. PubMed ID: 11686025
    [No Abstract]   [Full Text] [Related]  

  • 9. Contemporary definitions of tumor specific antigens, immunogens and markers as related to the adaptive responses of the cancer-bearing host.
    Coggin JH; Barsoum AL; Rohrer JW; Thurnher M; Zeis M
    Anticancer Res; 2005; 25(3c):2345-55. PubMed ID: 16080461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. About human tumor antigens to be used in immunotherapy.
    Lucas S; Coulie PG
    Semin Immunol; 2008 Oct; 20(5):301-7. PubMed ID: 18395462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Identification of tumor antigens: strategies and perspectives].
    Zippelius A; Knights A; Tinguely M; Jäger D; Renner C; Knuth A
    Dtsch Med Wochenschr; 2006 Aug; 131(33):1809-12. PubMed ID: 16902905
    [No Abstract]   [Full Text] [Related]  

  • 12. [Contemporary molecular-biological methods of cancer diagnosis and monitoring based on the humoral immune response to tumor-associated antigens].
    Shebzukhov IuV; Belousov PV; Khlgatian SV; Sazykin AIu; Kuprash DV; Nedospasov SA
    Mol Gen Mikrobiol Virusol; 2007; (2):3-6. PubMed ID: 17600920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can antibodies in serum predict the presence of microscopic tumors?
    Voltz R
    Neurology; 2007 Mar; 68(12):887-8. PubMed ID: 17372122
    [No Abstract]   [Full Text] [Related]  

  • 14. Cyclin B1 and other cyclins as tumor antigens in immunosurveillance and immunotherapy of cancer.
    Egloff AM; Vella LA; Finn OJ
    Cancer Res; 2006 Jan; 66(1):6-9. PubMed ID: 16397206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The function of tumor specific antigen (MAGE) in tumor immunotherapy].
    Fang JB; Wang L
    Sheng Li Ke Xue Jin Zhan; 2005 Jul; 36(3):273-5. PubMed ID: 16270835
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunotherapy and gene therapy of cancer using antibodies or their genes against tumor-associated antigens.
    Kuroki M; Shibaguchi H; Imakiire T; Uno K; Shirota K; Higuchi T; Shitama T; Yamada H; Hirose Y; Nagata A; Kuroki M
    Anticancer Res; 2003; 23(6a):4377-81. PubMed ID: 14666724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The reverse proteomics for identification of tumor antigens.
    Lee SY; Jeoung D
    J Microbiol Biotechnol; 2007 Jun; 17(6):879-90. PubMed ID: 18050904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the colorectal antigen IOR C2.II.
    Vázquez AM; Tormo B; Velandia A; Gómez CA; Alfonso M; Giscombe R; Ansotegui I; Jeddi-Tehrani M; Pérez R; Mellstedt H
    Year Immunol; 1993; 7():137-45. PubMed ID: 7690506
    [No Abstract]   [Full Text] [Related]  

  • 19. [Identification of cancer antigens of relevance for specific cancer immunotherapy].
    van den Eynde B
    Bull Mem Acad R Med Belg; 2001; 156(10-12):548-55. PubMed ID: 12371273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identifying tumor antigens in endocrine malignancies.
    Wuttke M; Papewalis C; Jacobs B; Schott M
    Trends Endocrinol Metab; 2009 Apr; 20(3):122-9. PubMed ID: 19269848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.